European shares climbed Tuesday, led by technology stocks boosted by strong forecasts from STMicroelectronics amid AI demand. Investors awa...

US President Donald Trump said there was a “very good chance” Washington and Iran could reach a deal to stop Tehran from developing a nucle...

A major private hospital group warns of a crisis for advanced cancer patients under the Central Government Health Scheme. A reimbursement c...

President Trump's administration projects significant savings from deals with drug companies. These agreements aim to lower US prescription...

London’s FTSE 100 edged lower as losses in energy majors and AstraZeneca weighed on the index amid thin holiday trading. Weak crude prices ...

India is a major global supplier of affordable generic medicines. The United States continues to pressure India regarding intellectual prop...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

U.S. stocks surged on Thursday, with the S&P 500 and Nasdaq achieving their largest monthly gains in years. Strong corporate earnings, part...

India and New Zealand signed a “once-in-a-generation” free trade agreement on Monday that gives New Delhi duty-free access to 100% of tarif...

Indian stock markets experienced sharp losses for the third consecutive session, with Sensex and Nifty falling over 1% each. Escalating Ira...

The United States has introduced tariffs on branded drug imports. However, many exemptions will limit their effect. Companies investing in ...

America is set to impose hefty 100% tariffs on imported medicines. This move targets drug companies that do not agree to government pricing...

Indian drug maker Sun Pharma faces significant exposure to potential US tariffs on medicines. Global brokerage Jefferies warns that while g...

The Trump administration is exploring a policy to link US drug prices to those of other developed nations. This move is causing concern in ...

U.S. tariffs on pharmaceuticals are unlikely to immediately raise brand-name drug prices, as drugmakers are expected to absorb initial cost...

The Biden administration announced agreements with drug companies to lower the cost of 10 major Medicare medications, potentially saving ta...

Multinational drugmakers may find this a raw deal from the Prime minister’s Office (PMO).